Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cluster-randomized effectiveness study of the 10-valent pneumococcal protein D conjugate vaccine in Finland
2008-005149-48Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of 10-valent pneumococcal and non-typeable haemophilus influenzae protein d conjugate vaccine in pneumococcal disease, invasive pneumococcal disease (IPD) and Haemophilus influenzae disease (3 arms), sponsored by GSK. Started Nov 2008; status: completed.
02
Drugs
10-valent pneumococcal and non-typeable haemophilus influenzae protein d conjugate vaccine
03
Conditions
pneumococcal diseaseinvasive pneumococcal disease (IPD)Haemophilus influenzae disease
Beyond the preview
Go deeper on 2008-005149-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005149-48.